Witfire editorial artwork illustrating the WIN378 asthma programme, with an antibody structure and human lungs representing long-acting TSLP blockade. The image is conceptual and does not depict the ...
BV100 Philippines trial plans list two hospitals. Witfire checks RIV-TARGET, revised readout dates, the antibiotic regimen and pending local recruitment.
Nerandomilast Philippines trial plans name three hospitals. Inside the Phase 3 systemic sclerosis study, its evidence, endpoints and pending local recruitment.
The FDA CPR renewal rule is narrower than a general grace period. A medical-device certificate can remain valid after its printed expiry while FDA review is pending, but only when the renewal was ...
Alevia-B is receiving fresh coverage in the Philippines through PascualLab’s 80th-anniversary portfolio campaign. Each tablet combines paracetamol with vitamins B1, B6 and B12. The Philippine FDA ...
RENGEVITY-201 trial dosing has begun, Veloxis says, with the first participant now treated. The Phase 2 study plans to randomise up to 120 kidney-transplant recipients across two pegrizeprument doses ...
Merck priced the first oral PCSK9 inhibitor at $10.50 a tablet. Amgen has been selling Repatha, in cash, for roughly eight dollars a day since October. That is the whole trade in two lines, and most ...
Bright scientific image illustrating eplontersen TTR silencing in transthyretin amyloid cardiomyopathy, cardiac amyloid burden and the challenge of adding a silencer to stabilizer therapy. HELIOS-B ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results